Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
August 27, 2002
A note on sample size calculation in bioequivalence trials
Dieter Hauschke
Biometrical Journal. Biometrische Zeitschrift
|
January 6, 2016
Methodological aspects of the benefit assessment of medical interventions
Dieter Hauschke, Claudia Schmoor
Pharmaceutical Statistics
|
November 4, 2006
Comment on 'Comparison of sample size formulae for 2 x 2 cross-over designs applied to bioequivalence studies', Siqueira AL, Whitehead A, Todd S and Lucini MM. Pharmaceutical Statistics 2005; 4:233-243
Dieter Hauschke, Dietrich Knoerzer
Biometrical Journal. Biometrische Zeitschrift
|
March 21, 2006
"Testing superiority and non-inferiority hypotheses in active controlled clinical trials"
Joachim Röhmel, Dieter Hauschke
Biometrical Journal. Biometrische Zeitschrift
|
February 3, 2006
Establishing efficacy of a new experimental treatment in the 'gold standard' design
Dieter Hauschke, Iris Pigeot
Alternatives to Laboratory Animals : ATLA
|
December 15, 2004
Two-stage testing of safety: a statistical view
Dieter Hauschke, Ludwig A Hothorn
Journal of Biopharmaceutical Statistics
|
October 26, 2011
The bootstrap in bioequivalence studies
Iris Pigeot, Dieter Hauschke, Jun Shao
Alternatives to Laboratory Animals : ATLA
|
December 15, 2004
The role of control groups in mutagenicity studies: matching biological and statistical relevance
Dieter Hauschke, Torsten Hothorn, Juliane Schäfer
Statistics in Medicine
|
March 11, 2003
Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo
Iris Pigeot, Juliane Schäfer, Joachim Röhmel, et al.
Biometrical Journal. Biometrische Zeitschrift
|
January 7, 2006
Biostatistical assessment of mutagenicity studies by including the positive control
Dieter Hauschke, Renate Slacik-Erben, Sabrina Hensen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Journal of Pharmacokinetics and Pharmacodynamics
|
August 27, 2002
A note on sample size calculation in bioequivalence trials
Dieter Hauschke
Biometrical Journal. Biometrische Zeitschrift
|
January 6, 2016
Methodological aspects of the benefit assessment of medical interventions
Dieter Hauschke, Claudia Schmoor
Pharmaceutical Statistics
|
November 4, 2006
Comment on 'Comparison of sample size formulae for 2 x 2 cross-over designs applied to bioequivalence studies', Siqueira AL, Whitehead A, Todd S and Lucini MM. Pharmaceutical Statistics 2005; 4:233-243
Dieter Hauschke, Dietrich Knoerzer
Biometrical Journal. Biometrische Zeitschrift
|
March 21, 2006
"Testing superiority and non-inferiority hypotheses in active controlled clinical trials"
Joachim Röhmel, Dieter Hauschke
Biometrical Journal. Biometrische Zeitschrift
|
February 3, 2006
Establishing efficacy of a new experimental treatment in the 'gold standard' design
Dieter Hauschke, Iris Pigeot
Alternatives to Laboratory Animals : ATLA
|
December 15, 2004
Two-stage testing of safety: a statistical view
Dieter Hauschke, Ludwig A Hothorn
Journal of Biopharmaceutical Statistics
|
October 26, 2011
The bootstrap in bioequivalence studies
Iris Pigeot, Dieter Hauschke, Jun Shao
Alternatives to Laboratory Animals : ATLA
|
December 15, 2004
The role of control groups in mutagenicity studies: matching biological and statistical relevance
Dieter Hauschke, Torsten Hothorn, Juliane Schäfer
Statistics in Medicine
|
March 11, 2003
Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo
Iris Pigeot, Juliane Schäfer, Joachim Röhmel, et al.
Biometrical Journal. Biometrische Zeitschrift
|
January 7, 2006
Biostatistical assessment of mutagenicity studies by including the positive control
Dieter Hauschke, Renate Slacik-Erben, Sabrina Hensen, et al.
Page
of 5